Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus
    24.
    发明申请
    Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus 有权
    他克莫司的单克隆抗体和他克莫司的免疫测定方法

    公开(公告)号:US20090087865A1

    公开(公告)日:2009-04-02

    申请号:US12239063

    申请日:2008-09-26

    摘要: An IgG1λ monoclonal antibody to the immunosuppressive drug tacrolimus has improved properties. In particular, this monoclonal antibody, designated 1H6, has reduced cross-reactivity to several tacrolimus metabolites. This antibody is suitable for performance of immunoassays such as homogeneous immunoassays to detect or determine the presence or concentration of tacrolimus in samples such as blood samples. The invention further includes derivatives of tacrolimus derivatized at a non-binding portion of the molecule useful in immunizing antibody-producing animals and in producing such monoclonal antibodies, as well as labeled derivatives of tacrolimus useful as tacrolimus analogues in such assays. The invention further includes immunoassay methods for the detection of tacrolimus and test kits useful in performing such immunoassays.

    摘要翻译: 针对免疫抑制药物他克莫司的IgG1λ单克隆抗体具有改善的性质。 特别地,称为1H6的单克隆抗体具有降低的几种他克莫司代谢物的交叉反应性。 该抗体适用于进行免疫测定,例如均匀免疫测定,以检测或确定样品如血液样品中他克莫司的存在或浓度。 本发明还包括在用于免疫产生抗体的动物和用于制备此类单克隆抗体的分子的非结合部分衍生的他克莫司的衍生物,以及在该测定中可用作他克莫司类似物的他克莫司的标记衍生物。 本发明还包括用于检测他克莫司的免疫测定方法和用于进行这种免疫测定的试剂盒。

    Sustained release of Apo A-I mimetic peptides and methods of treatment
    26.
    发明授权
    Sustained release of Apo A-I mimetic peptides and methods of treatment 有权
    持续释放Apo A-I模拟肽和治疗方法

    公开(公告)号:US09173890B2

    公开(公告)日:2015-11-03

    申请号:US11946028

    申请日:2007-11-27

    摘要: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.

    摘要翻译: 一种方法,包括使输送装置通过血管的内腔前进到血管中的特定区域; 并将包含持续释放载体和载脂蛋白AI(apo AI)合成模拟肽的组合物引入所述特定区域或血管周围部位的血管壁中,其中所述肽具有使所述肽有效反转的性质 胆固醇运输。 包含载体载脂蛋白AI(apo AI)合成肽或apo AI合成模拟肽和Acyl CoA胆固醇:酰基转移酶(ACAT)抑制剂的组合的组合物,其形式适于递送到血管中,所述肽包含氨基酸 序列以与各种apo AI模拟肽或内源性载脂蛋白AI类似物的顺序相反的顺序,或内源性apo AI的螺旋1和螺旋9的嵌合体。

    Method for the manufacture of stable, nano-sized particles
    30.
    发明授权
    Method for the manufacture of stable, nano-sized particles 有权
    用于制造稳定的纳米尺寸颗粒的方法

    公开(公告)号:US08273274B2

    公开(公告)日:2012-09-25

    申请号:US12727129

    申请日:2010-03-18

    申请人: Dariush Davalian

    发明人: Dariush Davalian

    IPC分类号: B06B1/00

    CPC分类号: A61K9/146

    摘要: The current invention relates to methods of making nano-particles of a material with a narrow polydispersity. The particle materials are active agents, organic compounds, polymers, and combinations thereof.

    摘要翻译: 本发明涉及制备具有窄多分散性的材料的纳米颗粒的方法。 颗粒材料是活性剂,有机化合物,聚合物及其组合。